Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional

Study of AQUAVAN® Injection (AQUAVAN; Fospropofol Disodium) for Sedation During Colonoscopy

ClinicalTrials.gov ID: NCT00125424

Public ClinicalTrials.gov record NCT00125424. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 12:06 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Dose-Response Study to Assess the Efficacy and Safety of AQUAVAN® Injection for Procedural Sedation in Patients Undergoing Colonoscopy

Study identification

NCT ID
NCT00125424
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Eisai Inc.
Industry
Enrollment
125 participants

Conditions and interventions

Interventions

  • AQUAVAN® (fospropofol disodium) Injection Drug
  • Midazolam HCl Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2005
Primary completion
Not listed
Completion
Aug 31, 2005
Last update posted
Nov 6, 2008

2005

United States locations

U.S. sites
20
U.S. states
15
U.S. cities
19
Facility City State ZIP Site status
Clinical Research Associates Huntsville Alabama 35801
Arizona Research Center Phoenix Arizona 85023
Atlanta Gastroenterology Associates Atlanta Georgia 30342
Rockford Gastroenterology Associates Ltd. Rockford Illinois 61107
Welborn Clinic Evansville Indiana 47713
Gulf Coast Research Associates, Inc. Baton Rouge Louisiana 70808
Gastroenterology Clinic Monroe Louisiana 71201
Chevy Chase Clinical Research Chevy Chase Maryland 20815
Endoscopic Microsurgery Associates, PA Towson Maryland 21204
Gastrointestinal Associates, PA Jackson Mississippi 39202
Winthrop-University Hospital Mineola New York 11501
Research Associates of New York New York New York 10021
Asheville Gastroenterology Associates/The Endoscopy Center Asheville North Carolina 28801
Oklahoma Gastroenterology Associates Tulsa Oklahoma 74104
Memphis Gastroenterology Group, PC Memphis Tennessee 38120
Gastrointestinal Institute Nashville Tennessee 37203
St. Thomas Medical Group, P.C. Nashville Tennessee 37205
Alamo Research Center San Antonio Texas 78215
Spokane Digestive Diseases Center Spokane Washington 99207
Wisconsin Center for Advance Research Milwaukee Wisconsin 53215

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00125424, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 6, 2008 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00125424 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →